111 related articles for article (PubMed ID: 15261229)
1. Clinical and genetic analysis of a family with PROMM.
Grewal RP; Zhang S; Ma W; Rosenberg M; Krahe R
J Clin Neurosci; 2004 Aug; 11(6):603-5. PubMed ID: 15261229
[TBL] [Abstract][Full Text] [Related]
2. An expansion in the ZNF9 gene causes PROMM in a previously described family with an incidental CLCN1 mutation.
Lamont PJ; Jacob RL; Mastaglia FL; Laing NG
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):343. PubMed ID: 14742629
[No Abstract] [Full Text] [Related]
3. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
4. Unusual clinical, laboratory, and muscle histopathological findings in a family with myotonic dystrophy type 2.
Toth C; Dunham C; Suchowersky O; Parboosingh J; Brownell K
Muscle Nerve; 2007 Feb; 35(2):259-64. PubMed ID: 17068784
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
Day JW; Ricker K; Jacobsen JF; Rasmussen LJ; Dick KA; Kress W; Schneider C; Koch MC; Beilman GJ; Harrison AR; Dalton JC; Ranum LP
Neurology; 2003 Feb; 60(4):657-64. PubMed ID: 12601109
[TBL] [Abstract][Full Text] [Related]
6. Does proximal myotonic myopathy show anticipation?
Kruse B; Wöhrle D; Steinbach P; Gal A
Hum Mutat; 2008 Aug; 29(8):E100-2. PubMed ID: 18484632
[TBL] [Abstract][Full Text] [Related]
7. Proximal myotonic myopathy: clinical and molecular investigation of a Norwegian family with PROMM.
Sun C; Henriksen OA; Tranebjaerg L
Clin Genet; 1999 Dec; 56(6):457-61. PubMed ID: 10665666
[TBL] [Abstract][Full Text] [Related]
8. Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2).
Kress W; Mueller-Myhsok B; Ricker K; Schneider C; Koch MC; Toyka KV; Mueller CR; Grimm T
Neuromuscul Disord; 2000 Oct; 10(7):478-80. PubMed ID: 10996776
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the diagnostic procedure in proximal myotonic myopathy/myotonic dystrophy type 2.
Jakubiczka S; Vielhaber S; Kress W; Küpferling P; Reuner U; Kunath B; Wieacker P
Neurogenetics; 2004 Feb; 5(1):55-9. PubMed ID: 14666402
[TBL] [Abstract][Full Text] [Related]
10. Myotonic dystrophy type 2.
Finsterer J
Eur J Neurol; 2002 Sep; 9(5):441-7. PubMed ID: 12220374
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
[TBL] [Abstract][Full Text] [Related]
12. The expanding clinical and genetic spectrum of the myotonic dystrophies.
Ricker K
Acta Neurol Belg; 2000 Sep; 100(3):151-5. PubMed ID: 11098287
[TBL] [Abstract][Full Text] [Related]
13. Proximal myotonic myopathy: evidence for anticipation in families with linkage to chromosome 3q.
Schneider C; Ziegler A; Ricker K; Grimm T; Kress W; Reimers CD; Meinck H; Reiners K; Toyka KV
Neurology; 2000 Aug; 55(3):383-8. PubMed ID: 10932272
[TBL] [Abstract][Full Text] [Related]
14. A family with PROMM not linked to the recently mapped PROMM locus DM2.
Wieser T; Bönsch D; Eger K; Schulte-Mattler W; Zierz S
Neuromuscul Disord; 2000 Feb; 10(2):141-3. PubMed ID: 10714590
[TBL] [Abstract][Full Text] [Related]
15. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
[TBL] [Abstract][Full Text] [Related]
16. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
[TBL] [Abstract][Full Text] [Related]
17. [Myotonic dystrophy type 2].
Kimura T; Saito T
Brain Nerve; 2011 Nov; 63(11):1151-60. PubMed ID: 22068467
[TBL] [Abstract][Full Text] [Related]
18. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.
Raheem O; Olufemi SE; Bachinski LL; Vihola A; Sirito M; Holmlund-Hampf J; Haapasalo H; Li YP; Udd B; Krahe R
Am J Pathol; 2010 Dec; 177(6):3025-36. PubMed ID: 20971734
[TBL] [Abstract][Full Text] [Related]
19. Proximal myotonic myopathy: clinical, electrophysiological and pathological findings in a family.
Kohler A; Burkhard P; Hefft S; Bottani A; Pizzolato GP; Magistris MR
Eur Neurol; 2000; 43(1):50-3. PubMed ID: 10601809
[TBL] [Abstract][Full Text] [Related]
20. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
